NCT07284849 2026-04-16A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerIncyte CorporationPhase 3 Recruiting700 enrolled